Investi Stratix
  • Politics
  • Economy
  • Forex
  • Stock
  • Editor’s Pick
  • Politics
  • Economy
  • Forex
  • Stock
  • Editor’s Pick
No Result
View All Result
Investi Stratix
No Result
View All Result

China state media dismiss Trump’s tariff vow, focus on fentanyl

by
November 27, 2024
in Stock
0
China state media dismiss Trump’s tariff vow, focus on fentanyl

By Joe Cash

BEIJING (Reuters) – China’s state media shrugged off U.S. President-elect Donald Trump’s pledge to slap additional tariffs on Chinese goods in editorials late on Tuesday, accusing the former president of blaming China for the country’s failure to address the fentanyl crisis.

Trump, who takes office on Jan. 20, said on Monday he would impose “an additional 10% tariff, above any additional tariffs” on imports from China. He previously said he would introduce tariffs in excess of 60% on Chinese goods.

The tariff threat is rattling China’s industrial complex, which sells goods worth more than $400 billion annually to the U.S. and hundreds of billions more in components for products Americans buy from elsewhere.

Economists have begun downgrading their growth targets for the $19 trillion economy for 2025 and 2026.

Editorials in Chinese communist party mouthpieces China Daily and the Global Times focused squarely on the reason Trump gave for imposing the tariffs: fentanyl.

“Scapegoating others can’t end U.S.’ drug crisis,” read the headline of a China Daily editorial on Tuesday, while the Global Times urged the “U.S. not to take China’s goodwill for granted regarding anti-drug cooperation after Trump’s remarks.”

“The excuse the president-elect has given to justify his threat of additional tariffs on imports from China is farfetched,” China Daily said. “The world sees clearly that the root cause of the fentanyl crisis in the U.S. lies with the U.S. itself,” it added.

“There are no winners in tariff wars. If the U.S. continues to politicise economic and trade issues by weaponising tariffs, it will leave no party unscathed.”

Trump’s team maintains China is “attacking” the U.S. with fentanyl.

China is the dominant source of chemical precursors used by Mexican cartels to produce the deadly drug. Trump on Monday also pledged 25% tariffs on goods coming from Mexico and Canada until they clamp down on drugs and migrants crossing the border.

Trump is threatening Beijing with far higher tariffs than the 7.5%-25% levied on Chinese goods during his first term.

S&P Global on Sunday lowered its growth forecast for China for 2025 and 2026 by 0.2 and 0.7 percentage point, respectively, to 4.1% and 3.8%, citing the impact Trump’s tariffs could have.

“What we assumed in our baseline is an across-the-board increase from around 14% now to 25%. Thus, what we assumed is a bit more than the 10% on all imports from China,” said Louis Kuijs, Chief Asia Economist at S&P Global Ratings.

“For now the only thing we know for sure is that the risks in this area are high.”

This post appeared first on investing.com
Previous Post

Stellantis to close Luton van factory in UK owing to country’s strict EV mandate

Next Post

Exclusive-In careful protest, China Evergrande’s investors press for action

Next Post
Exclusive-In careful protest, China Evergrande’s investors press for action

Exclusive-In careful protest, China Evergrande’s investors press for action

Subscribe to InvestiStratix.com

    Popular News

    How billionaire Caltagirone could influence Italy’s banking M&A wave

    How billionaire Caltagirone could influence Italy’s banking M&A wave

    July 21, 2025
    US visa bans on Brazilian judges spark diplomatic rift, cloud economic ties

    US visa bans on Brazilian judges spark diplomatic rift, cloud economic ties

    July 20, 2025
    The new global demographic challenge: not too many, but too few

    The new global demographic challenge: not too many, but too few

    July 20, 2025
    How billionaire Caltagirone could influence Italy’s banking M&A wave

    How billionaire Caltagirone could influence Italy’s banking M&A wave

    July 20, 2025
    Sarepta shares fall 37% as FDA questions future of key gene therapy

    Sarepta shares fall 37% as FDA questions future of key gene therapy

    July 19, 2025

    Trending News

    How billionaire Caltagirone could influence Italy’s banking M&A wave

    How billionaire Caltagirone could influence Italy’s banking M&A wave

    July 21, 2025
    US visa bans on Brazilian judges spark diplomatic rift, cloud economic ties

    US visa bans on Brazilian judges spark diplomatic rift, cloud economic ties

    July 20, 2025

    Popular News

    • How billionaire Caltagirone could influence Italy’s banking M&A wave
      July 21, 2025
    • How billionaire Caltagirone could influence Italy’s banking M&A wave
      July 20, 2025

    About Us

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 investistratix.com | All Rights Reserved

    No Result
    View All Result
    • Politics
    • Economy
    • Forex
    • Stock
    • Editor’s Pick

    Copyright © 2025 investistratix.com | All Rights Reserved